Staged criticality test on immune clone-size distributions: three-generator BIC on the full snapshot (Arm 1) + declustering-unmixing validation on the triggered subset (Arm 2); lineage-restricted autoreactive differential as autoimmunity early-warning observable
Earthquake math could detect autoimmune disease before symptoms appear by reading immune cell population patterns.
Mean-field critical-branching upper cutoff x_c ~ (1-n)^-2 as the BIC-discriminating feature distinguishing branching criticality from a fluctuating-fitness null in immune clone-size distributions, with ETAS declustering to unmix the two generators.
6 bridge concepts›
How this score is calculated ›How this score is calculated ▾
6-Dimension Weighted Scoring
Each hypothesis is scored across 6 dimensions by the Ranker agent, then verified by a 10-point Quality Gate rubric. A +0.5 bonus applies for hypotheses crossing 2+ disciplinary boundaries.
Is the connection unexplored in existing literature?
How concrete and detailed is the proposed mechanism?
How far apart are the connected disciplines?
Can this be verified with existing methods and data?
If true, how much would this change our understanding?
Are claims supported by retrievable published evidence?
Composite = weighted average of all 6 dimensions. Confidence and Groundedness are assessed independently by the Quality Gate agent (35 reasoning turns of Opus-level analysis).
RQuality Gate Rubric
7/17 PASS · 10 CONDITIONAL
| Criterion | Result |
|---|---|
| Novelty | 8 |
| Testability | 8 |
| Groundedness | 5 |
| ABC Structure | PASS |
| Test Protocol | PASS |
| Impact Paradigm | 6 |
| Counter-Evidence | PASS |
| Precision | CONDITIONAL |
| Per Claim Grounding | CONDITIONAL |
| Cross Field Distance | 8 |
| Impact Translational | 6 |
| Novelty Web Verified | PASS |
| Mechanism | PASS |
| Confidence | PASS |
| Falsifiable | PASS |
| Mechanistic Specificity | 6 |
| Groundedness Reflects Evidence | CONDITIONAL |
Claim Verification
Empirical Evidence
How EES is calculated ›How EES is calculated ▾
The Empirical Evidence Score measures independent real-world signals that converge with a hypothesis — not cited by the pipeline, but discovered through separate search.
Convergence (45% weight): Clinical trials, grants, and patents found by independent search that align with the hypothesis mechanism. Strong = direct mechanism match.
Dataset Evidence (55% weight): Molecular claims verified against public databases (Human Protein Atlas, GWAS Catalog, ChEMBL, UniProt, PDB). Confirmed = data matches the claim.
Seismologists have spent decades developing mathematical tools to understand how earthquakes trigger aftershocks — and crucially, whether a cascade of tremors will fizzle out or spiral into something catastrophic. The key concept is a 'branching ratio': if each earthquake produces on average less than one aftershock, the sequence dies; if it produces more than one, you get a runaway chain reaction. Meanwhile, immunologists have discovered that our immune memory isn't static — when a vaccine or infection reactivates memory cells, those cells can multiply in chains, with one activated clone spawning others, in a process that looks mathematically very similar to earthquake aftershock sequences. This hypothesis proposes borrowing the earthquake toolkit wholesale and applying it to data from immune cell sequencing — the technology that lets us count how many copies of each unique immune cell 'clone' exist in a blood sample at any given moment. The idea is that the shape of that distribution (lots of rare clones, a few huge ones) contains a hidden signature that tells you whether the immune system is humming along in a safe, self-limiting way, or edging toward a dangerous runaway state. Three competing mathematical models are pitted against each other in a rigorous statistical shootout to see which one best describes the data. The really clever part is a specific application to autoimmunity — diseases like lupus or rheumatoid arthritis, where the immune system attacks the body's own tissues. The hypothesis proposes measuring whether self-attacking ('autoreactive') immune clones follow a different branching pattern than the overall immune population. If they do, the difference between those two patterns could act as an early warning signal, potentially detectable years before a person develops any symptoms of autoimmune disease.
This is an AI-generated summary. Read the full mechanism below for technical detail.
Why This Matters
If confirmed, this approach could transform autoimmune disease diagnosis from reactive — waiting for symptoms to appear — to predictive, potentially giving clinicians a years-long head start to intervene with preventive therapies. The statistical framework, if validated, could be applied to existing immune sequencing datasets already collected in clinical trials and biobanks without requiring new experiments. It could also sharpen our understanding of when vaccines or immune therapies risk tipping a patient's immune system toward dangerous overactivation. The hypothesis is speculative enough to warrant caution, but testable enough with currently available data that the cost of checking is low relative to the potential payoff.
Mechanism
Three generators produce separable static clone-size signatures, tested in a pre-registered BIC competition (size-frequency/Pareto convention): (A) near-critical branching, a power law with upper cutoff x_c ~ (1-n)^-2 (Zapperi-Lauritsen-Stanley mean-field result); (B) fluctuating-fitness steady state (Desponds-Mora-Walczak 2016), power-law tail with no criticality cutoff; (C) lognormal. Arm 1 fits all three to existing BCR/TCR-seq and the BIC winner is the deliverable regardless of outcome. Arm 2 (conditional) applies ETAS declustering first to physically unmix the fluctuating-fitness background pool from the active branching triggered pool, then runs BIC separately on each, converting the Desponds confound into an asset. A lineage-restricted autoreactive differential D = alpha_global - alpha_autoreactive is proposed as a pre-clinical autoimmunity lead-time observable. NOTE (QG correction pending): the mechanism text incorrectly asserts the two generators share an identical exponent; they differ by ~2x, which makes BIC discrimination easier.
Supporting Evidence
QG-verified citations: Zapperi, Lauritsen & Stanley 1995 PRL 75:4071 (mean-field tau=3/2, cutoff (1-n)^-2); Desponds, Mora & Walczak 2016 PNAS 113:274-279 (fluctuating-fitness clone-size power law); Clauset, Shalizi & Newman 2009 SIAM Rev (power-law/lognormal model comparison; powerTCR); Zhuang, Ogata & Vere-Jones 2002 (declustering); Klaus, Yu & Plenz 2011 PLoS ONE (truncated-power-law vs lognormal in neural avalanches).
How to Test
Arm 1 (3-6 months, no new data): >=3 existing post-boost BCR/TCR-seq datasets (>=10^4 cells); empirical x_min estimation (Clauset-Shalizi-Newman); pre-registered three-way BIC in Pareto convention; if (A) wins, cross-check (1-n) from cutoff against event-time branching-ratio MLE (r>0.6). Arm 2 (conditional, 6-12 months): ETAS declustering of d0-baseline vs d3-d28 events, R=100 Monte Carlo, accept if triggered-pool exponent IQR<0.15, requires N_triggered>=5000 (N_total>=25,000). Autoimmunity arm (12-24 months): pre-clinical RA/lupus biobank, serial BCR-seq, >=20 progressors + 20 non-progressors; D>0.1 in >=60% progressors >=6 months pre-seroconversion, FPR<=20%.
Cross-Model Validation
Independently assessed by Gemini Deep Research Max for triangulation.
Other hypotheses in this cluster
Can you test this?
This hypothesis needs real scientists to validate or invalidate it. Both outcomes advance science.